Commercial Biotechnology Separation Systems - Global Strategic Analysis

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY 1. OUTLOOK
Separation Technologies Drive Biotechnology Industry
Developed Markets Lead the Way while Emerging Markets Promise Growth
Liquid Chromatography Leads Biotechnology Separation Technologies

2. INDUSTRY OVERVIEW, TRENDS & DRIVERS
Bioseparation Systems
Invaluable Tools in Biopharmaceutical Manufacturing
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products
An Overview
Growing Biopharmaceuticals Market Drives Demand for Bioseparation Systems
2014-15: A Launch-Driven Period for Biopharmaceuticals
Recently Approved Biopharmaceuticals: 2013, 2014 & 2015
Evolving Biopharmaceutical Industry Emphasizes on Novel Technologies
Increasing Competition Spurs Renewed Focus on Efficiencies
Growing Orphan Drugs Market Draws Attention towards Manufacturing Flexibility
Downstream Processing
A Major Trend among Biopharmaceutical Manufacturers
Upstream and Downstream Mismatch Turns Focus towards Innovative Technologies
Protein Separation in Biopharmaceutical Space Assumes Greater Significance
Growing Market for Monoclonal Antibodies
Review of Current Status and Future Prospects
Approved Monoclonal Antibodies for Therapeutic Use: 1986-2014
An Insight into Bioseparation of mAbs
Market Potential for Biosimilars
A Case for Substantial Demand for Separation Technologies
Table 1: Global Biosimilars Market in US$ Billion for 2012-2018 (includes corresponding Graph/Chart)
2015: A Year of Patent Expiries for Biologics
Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
Huge Biopharmaceutical Pipeline
A Clear Indicator of Future Prospects
Table 2: Biopharmaceutical Products Pipeline by Therapeutic Category (2015) (includes corresponding Graph/Chart)
Table 3: Number of Pipeline Biopharmaceuticals for Cancer by Site (2015) (includes corresponding Graph/Chart)
Table 4: Number of Pipeline Biopharmaceuticals for HIV/AIDS Treatment by Type of Therapy (2015) (includes corresponding Graph/Chart)
Disposables to Infuse Cost Effectiveness in Biopharmaceutical Production
Single-Use Products Gain Significant Attention
Market Prospects for Single-Use Disposable Technologies
Select Commercial Disposable/Single-Use Technologies by Process Technique
Innovations in Single-use Systems
Modular Bioprocessing
An Emerging Trend
Leachables and Extractables Trounce Enthusiasm around Disposables

3. SEPARATION TECHNOLOGIES
MARKET ANALYSIS
Chromatography
the Gold Standard Separation and Purification Technology
Market Outlook
Ongoing Developments and Innovations Create Strong Demand for Columns
Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
Pre-packed Disposable Columns in Chromatography Gain Attention
Clinical Trials
the Largest Market for Pre-packed Disposable Columns
GE Leads Pre-packed Disposable Columns Market for Chromatography
Table 5: Leading Players in the Global Pre-packed, Disposable Columns for Chromatography (2014): Percentage Breakdown of Revenues for Atoll Bio, EMD-Millipore, GE Healthcare, Repligen and Others (includes corresponding Graph/Chart)
SMBC
An Old Approach Gaining Significant Attention
Major Advantages and Disadvantages of SMBC
Twin-Column SMB
An Emerging Alternative to Protein A Columns
Growing Focus on Alternatives to Protein A Chromatography
Precipitation and Crystallization
Techniques with Major Use in Protein Purification
Reversible Precipitation
A Novel Bioseparation Technology
Alternatives to Protein A-based Chromatography to See Significant Adoption
Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
Microarrays Witness Tremendous Growth
Protein Biochips
Set for Robust Expansion
Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
Current Approaches to Biochips
Advancements in Biochip Technology
Technological Differentiation in Demand
Biochip Technology Boosts Personalized Medicine
Biochip Technology Spreads beyond Pharma Industry
Data on Specificity of Effect Drives Use of Microarrays in Cosmetics and Personal Healthcare
Need for Alternative Techniques
The Key Drawback
Membrane Separation
A Promising Separation Technology
Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
Membrane Filtration Gains Widespread Application in Food Industry
Membrane Separation in Dairy Industry
A Note on Applications of Select Other Membrane Technologies in Dairy Industry
Ultrafiltration
A Widely Used Technique for Mineral Separation from Milk Products
Polymeric Membrane-based Separations Gain Attention in Dairy Sector
Novel Techniques Emerge to Prevent Solubility of Milk Protein Concentrate
Flow Cytometry
A Key Laboratory Analytical Technology
Developing Countries Present Growth Opportunities
Cell-based Flow Cytometry Lead the Pack
Research & Clinical Laboratories
Largest End-Use Segments
A Gist of Major Growth Drivers
Growth Barriers/Key Challenges
Technological Advances Boost Cytometric System Sales
Novel Cytometers Advance Technological Evolution
Mass Cytometry
A New Technology in Flow Cytometry
Microfluidics Take Cell Sorting to a New Level
Flow Cytometer Faces Competition from Alternative Instruments
Increasing Role of Flow Cytometry in Disease Diagnosis
IVD Application Market Set to Rise
Large-Scale Screening Operations
Untapped Domain
Rising Use of Image Flow Cytometry in Clinical Applications
Rising HIV Prevalence Provides Growth Opportunities for POC Flow Cytometry
Competitive Scenario in the Global Flow Cytometry Market
Table 6: Leading Players in the Global Flow Cytometers Market (2013): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD), Danaher/Beckman Coulter, and Others (includes corresponding Graph/Chart)
Centrifugation
A Key Separation Technology in Biopharmaceutical Production
Growing Proteomic Research Drives Demand for Electrophoresis Equipment
Major Application Areas of Electrophoresis Equipment
Table 7: Global Capillary Electrophoresis Equipment Market by Application Sector (2013): Percentage Share Breakdown of Value Sales for Pharmaceutical, Bioscience, Chemical, Food/Beverages and Other Application Sectors (includes corresponding Graph/Chart)
Capillary Electrophoresis Gains Prominence
2D Gel Electrophoresis Market Gains Ground
Overview of the 2D Gel Electrophoresis Market
Advent of 2D-DIGE
Table 8: World 2D Gel Electrophoresis Market by Segment (2013): Percentage Share Breakdown of Value Sales for Reagents, Instruments/ Apparatus and Informatics (includes corresponding Graph/Chart)
Factors Driving Growth of Two-Dimensional Gel Electrophoresis Market
Reconfigured by Technology
Product Innovations Sustain Sales
Advanced Gel-Imaging Systems: An Emerging Market with Promising Growth
High Level of Fragmentation Typifies Electrophoresis Competitive Landscape
Magnetic Separations
An Overview

4. PRODUCT OVERVIEW
Biotechnology Separation Systems
An Overview
Flow Cytometry
An Introduction
Flow Cytometers
Fluidics System
Optical System
Electronics System
Application Areas
An Overview
Versatile Use
Clinical Applications
Research Applications
Drug Discovery
Biomedical Research
Fetal Cell Separation
Stem Cell Sorting
Marine Biology and Environmental Sciences
Microbiology
Chromatography: A Popular Separation Technology
Liquid Chromatography
An Overview
General Scheme
Column Chromatography
Chromatography Components
Mobile Phase
Stationary Phase
Advantages and Disadvantages of Different Types of Liquid Chromatography
Membrane Separation
Biochips
Complex Blend of Biochemistry and Electronics
Classification of Biochips
Microarrays
Centrifuges
A Technical Overview
Batch and Semi-Batch Centrifugation
Types of Preparative Centrifuges
Tubular Bowl Centrifuge
Disk Stack Centrifuge
Chamber Bowl
Ultracentrifuge
Decanter Centrifuge
Centrifugal Filter
Electrophoresis
Types of Electrophoresis
Conventional/Gel Electrophoresis
Slab Gel Electrophoresis
Polyacrylamide Gel Electrophoresis (PAGE)
Two-Dimensional Gel Electrophoresis
Capillary Electrophoresis
Advantages of Capillary Electrophoresis Instruments
Enables Sizing of a Piece of DNA Down to a Single Base
Exhibits High Resolution and Fluorescently Labels Multiplexed PCR Products
Allow Rapid Separations Due to Generation of High Voltages
Produces Reliable Analysis Results
Allows Residual Disease Testing of Engraftment Studies of Bone Marrow Transplant
Allows Testing for FLT3 Mutation
Separation Techniques Employed in CE

5. PRODUCT INNOVATIONS/INTRODUCTIONS
EMD Millipore Launches Sterilizing-Grade Millipore Express® PHF Hydrophilic Filters
Novasep Unveils BioSC® Lab
EMD Millipore Unveils Pellicon® Tangential Flow Filtration System
ImmunoReagents and ProteoVec Launch PV-Pure Ig™ Antibody Purification Kits
BASF Launches PRODIAS Project in Collaboration with Eight Partners
AMSBIO Introduces MagSi-Direct for Bioseparations
EMD Millipore Rolls Out PureFlex™ Plus Disposable Process Container Film
EMD Millipore Rolls Out New Resins for Chromabolt® Chromatography Columns
Thermo Fisher Scientific Launches New Chromatography Resin
Thermo Fisher Scientific to Introduce GlycanPac AXR-1 Column at Pittcon 2014
Purolite to Develop Bioseparation Resins for Chromatography
EMD Millipore Unveils Innovative Single-Stage Clarification Clarisolve® Depth Filters
Novasep Rolls Out Sius™ Single-Use TFF Skid
Thermo Fisher Scientific Introduces New 3000 BioRS System
Thermo Fisher Scientific Launches SEC-300 and SEC-1000 HPLC Columns
EMD Millipore Introduces Smart Flexware® Assemblies Along with Mobius® FlexReady Solution

6. RECENT INDUSTRY ACTIVITY
Merck Acquires Sigma-Aldrich
Novasep and CPI Install BioSC Lab at UK National Biologics Manufacturing Centre
Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind™ Technology
Pall Inks Exclusive License for AWS Technology from FDS
Novasep Inks Partnership with Allied Laboratories and AR Brown
Pall Acquires Tarpon’s BioSMB Platform
Stora Enso Takes Over Virdia
Pall Corporation Acquires ATMI’s Life Sciences Business Division
AB Sciex and Beckman Coulter Combine CE and Chromatography Businesses

7. FOCUS ON SELECT PLAYERS
3M Purification, Inc. (US)
AB Sciex (US)
Affymetrix, Inc. (US)
Agilent Technologies, Inc. (US)
Alfa Laval AB (Sweden)
Alfa Wassermann Inc. (US)
Atoll GmbH (Germany)
Beckman Coulter, Inc. (US)
Becton, Dickinson and Company (US)
Bio-Rad Laboratories, Inc. (US)
Flottweg SE (Germany)
Fluidigm Corporation (US)
GE Healthcare (UK)
Groupe Novasep (France)
Hitachi Koki Co., Ltd. (Japan)
Illumina, Inc. (US)
Merck KGaA (Germany)
Pall Corporation (US)
PerkinElmer, Inc. (US)
ProMetic Life Sciences, Inc. (Canada)
Repligen Corporation (US)
Sartorius Stedim Biotech SA (France)
SEPMAG Technologies (Spain)
Shimadzu Scientific Instruments (US)
Spectrum Laboratories, Inc. (US)
Sysmex Partec GmbH (Germany)
Thermo Fisher Scientific, Inc. (US)

8. GLOBAL MARKET PERSPECTIVE
Table 9: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 10: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 11: World 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 12: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Type
DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Commercial Biotechnology Separation Systems by Type
DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 14: World 14-Year Perspective for Commercial Biotechnology Separation Systems by Type
Percentage Breakdown of Revenues for DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current & Future Analysis
United States: The Largest Biopharmaceutical Market Globally
Table 15: No. of Biologics Approved by the Center for Biologics Evaluation and Research (CBER): 2003-2013 (includes corresponding Graph/Chart)
Impending Patent Expiries Signal Growth Prospects
Table 16: Leading US Biopharmaceuticals by Revenue (in US$ Billion) and Year of Patent Expiry (includes corresponding Graph/Chart)
Select Trends in Biopharmaceutical Market
Manufacturers Shift Focus to Small Bioreactors
Biosimilar Drug Developers Face Higher Litigation Risks
US Flow Cytometry Market
An Overview
Table 17: Leading Players in the US Flow Cytometry Market (2014): Percentage Breakdown of Sales for Becton Dickinson, Beckman Coulter, and Others (includes corresponding Graph/Chart)
Growth in Protein Electrophoresis Segment to Persist
Factors Influencing Purchasing Decisions in Protein Electrophoresis Equipment Market
Major Factors Influencing Purchasing Decision for Protein Electrophoresis
Key Trends in the US PE Market
Ready-Made Gels Grow at the Expense of Hand-Cast Gels
Product Launches
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 18: US Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 19: US Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current & Future Analysis
Canada
A Lucrative Biopharmaceutical Industry
Key Player
B.Market Analytics
Table 20: Canadian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 21: Canadian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
Key Player
B.Market Analytics
Table 22: Japanese Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 23: Japanese Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current & Future Analysis
European Biopharmaceutical Industry
Select Trends
Funding Challenges Faced by Biopharmaceutical Startups
Healthcare Agencies Looking to Embrace Biosimilars to Cut Healthcare Costs
B.Market Analytics
Table 24: European Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 25: European Historic Review for Commercial Biotechnology Separation Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 26: European 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE
A.Market Analysis
Current & Future Analysis
Product Launches
Key Players
B.Market Analytics
Table 27: French Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 28: French Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
Key Players
B.Market Analytics
Table 29: German Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 30: German Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY
Market Analysis
Table 31: Italian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 32: Italian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
A.Market Analysis
Current & Future Analysis
Product Launch
Strategic Corporate Developments
Key Player
B.Market Analytics
Table 33: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 34: UK Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN
A.Market Analysis
Current & Future Analysis
Key Player
B.Market Analytics
Table 35: Spanish Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 36: Spanish Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. RUSSIA
A.Market Analysis
Current & Future Analysis
Russia Sets Eyes on Emerging as a Notable Pharmaceutical Industry
Encouragement for Local Manufacturing to Drive Demand
Challenges
Need for Extensive R&D
B.Market Analytics
Table 37: Russian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 38: Russian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4g. REST OF EUROPE
A.Market Analysis
Current & Future Analysis
Key Player
B.Market Analytics
Table 39: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 40: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Asia Set to Emerge as Preferred Outsourcing Destination for Biopharma Manufacturing
B.Market Analytics
Table 41: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 42: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 43: Asia-Pacific 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region
Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA
Market Analysis
Table 44: Chinese Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 45: Chinese Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5b. INDIA
A.Market Analysis
Current & Future Analysis
Favorable End-use Market Dynamics Drive Demand for Flow Cytometers
Table 46: Flow Cytometry Market in India (2014): Percentage Breakdown of Sales by End-Use Industry
Life Sciences, Clinical Research and Pharmaceutical (includes corresponding Graph/Chart)
Table 47: Indian Market for Flow Cytometers by Product (2013): Percentage Share Breakdown of Value Sales for Instruments and Reagents (includes corresponding Graph/Chart)
Table 48: Indian Market for Flow Cytometers Reagents (2013): Percentage Share Breakdown of Value Sales by Application (includes corresponding Graph/Chart)
Factors Affecting the Market
Competitive Landscape in the Indian Flow Cytometry Market
Indian Electrophoresis Market
An Overview
Key Growth Drivers of The Electrophoresis Market
Drug Production Requirements Boost Growth
Competitive Landscape
B.Market Analytics
Table 49: Indian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 50: Indian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 51: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 52: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA
Market Analysis
Table 53: Middle East & African Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 54: Middle East & African Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

7. LATIN AMERICA
Market Analysis
Table 55: Latin American Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 56: Latin American Historic Review for Commercial Biotechnology Separation Systems by Geographic Region
Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 57: Latin American 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region
Percentage Breakdown of Revenues for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 46 (including Divisions/Subsidiaries 51)
The United States (27)
Canada (1)
Japan (4)
Europe (16)

• France (2)
• Germany (8)
• The United Kingdom (1)
• Spain (2)
• Rest of Europe (3)

Asia-Pacific (Excluding Japan) (3)